<li id="nwtir"></li>
      
      
      <rp id="nwtir"><object id="nwtir"><blockquote id="nwtir"></blockquote></object></rp>

      <button id="nwtir"></button>

      <li id="nwtir"></li>
      <em id="nwtir"><tr id="nwtir"></tr></em><button id="nwtir"><acronym id="nwtir"></acronym></button>
    1. <button id="nwtir"><acronym id="nwtir"></acronym></button>
      Home
      About
      Products
      Specialties
      Gastrointestinal Surgery
      Urology
      Thoracic Surgery
      Gynecology
      Hepatic-biliary-pancreatic Surgery
      Thyroid & Breast Surgery
      Support
      User Manual
      REACH
      DEMO
      Contact
      CN
      About Us

      Shanghai SAINTS SAGES Surgical Co., Ltd. is committed to be a leader in the field of minimally invasive devices.


      With head office in Shanghai Zhangjiang Science City, Saints Sages has overall layout of the upstream and downstream of the industrial chain in Shanghai, Jiangsu and Hunan. We’re mainly engaged in R&D, production and sales of minimally invasive surgical medical devices.


      Established in 2017, Saints Sages has successfully developed several energy device products which are widely used in minimally invasive surgery, hepatobiliary surgery, gynecology, urology, thoracic surgery and other departments. We have full core intellectual property rights in related product fields, and some products are the first in the world.


      As a minimally invasive surgical innovation medical device company based in China and has vision for global markets, Saints Sages will continue to closely follow the clinical needs and develop more innovative minimally invasive surgical devices to serve global patients by relying on the professional R&D team and years of clinical transformation experiences.

      History
      2017.12
      2018.08
      2019.08
      2020.07
      2020.09
      2020.11
      2020.11
      2021.11

      Company establishment

      The Company received multimillion USD of angel round investment led by Vocanics Capital with Highlight Capital following.

      The Company received multimillion USD of Pre-A round investment led by Northern Light Venture Capital with Lapam Capital following.


      SanAgile I completed clinical trial enrollments at Shanghai Ruijin Hospital and Shanghai Changzheng Hospital.

      SanAgile I completed animal experiments.

      The Company received 15M USD of round A investment led by Qiming Venture Partners with TF Capital following.

      SanPulse I completed development.

      Culture
      • We seamlessly integrate clinical needs and assist medics to improve patients’ postoperative recovery as well as their wellbeing

      • We conduct independent R&D as well as innovation and commit to take innovation as the first driving force.

      • Implementing the life cycle of medical products, we always take "win-win" as the principle to ensure the healthy development of resource-based ecological chain.

      • We take the development of the industry as our own responsibility and use our knowledge to promote the healthy and sustainable development of China's medical industry.

      欧美大黑吊操逼